LONDON, October 29, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals, the multinational pharmaceutical group, announces that it has signed an agreement to acquire Baxter Healthcare Corporation's US generic injectables business for a cash consideration of $112 million.
There will be a live analyst and investor webcast outlining the event on http://www.cantos.com at 0930 BST. An on-demand replay of the webcast will also be available.
Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email email@example.com or phone +44-207-936-1352.
SOURCE Hikma Pharmaceuticals